Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide.

Acetazolamide, a carbonic anhydrase inhibitor, remains the only FDA approved pharmaceutical prophylaxis for acute mountain sickness (AMS) though its effectiveness after rapid transport in real world conditions is less clear.

Bibliographic Details
Published in:PLOS ONE
Main Authors: Harrison, Michael F, Anderson, Paul J, Johnson, Jacob B, Richert, Maile, Miller, Andrew D, Johnson, Bruce D
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science 2016
Subjects:
South pole
Online Access:https://doi.org/10.1371/journal.pone.0148206
https://pubmed.ncbi.nlm.nih.gov/26848757
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744068/
Description
Summary:Acetazolamide, a carbonic anhydrase inhibitor, remains the only FDA approved pharmaceutical prophylaxis for acute mountain sickness (AMS) though its effectiveness after rapid transport in real world conditions is less clear.

Similar Items